Clinical Trial Update: Reduced Intensity Allogeneic PBSCT to Treat Hematologic Malignancies and Hematopoietic Failure States [Phase 2]

View source ↗

Summary

Phase 2 trial investigating reduced-intensity allogeneic peripheral blood stem cell transplantation for hematologic malignancies and hematopoietic failure state…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia Aplastic
• Hematologic Neoplasms
• Hemoglobinuria Paroxysmal
• Multiple Myeloma
• Myelofibrosis

Snippet

Sponsor: University of Arizona | Conditions: Hematologic Neoplasms, Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2018-12-24